| Literature DB >> 34187361 |
Henry Reyer1, Michael Oster1, Siriluck Ponsuksili1, Nares Trakooljul1, Adewunmi O Omotoso1, Muhammad A Iqbal1, Eduard Muráni1, Vera Sommerfeld2, Markus Rodehutscord2, Klaus Wimmers3,4.
Abstract
BACKGROUND: Calcium (Ca) and phosphorus (P) are essential nutrients that are linked to a large array of biological processes. Disturbances in Ca and P homeostasis in chickens are associated with a decline in growth and egg laying performance and environmental burden due to excessive P excretion rates. Improved utilization of minerals in particular of P sources contributes to healthy growth while preserving the finite resource of mineral P and mitigating environmental pollution. In the current study, high performance Lohmann Selected Leghorn (LSL) and Lohmann Brown (LB) hens at peak laying performance were examined to approximate the consequences of variable dietary Ca and P supply. The experimental design comprised four dietary groups with standard or reduced levels of either Ca or P or both (n = 10 birds per treatment group and strain) in order to stimulate intrinsic mechanisms to maintain homeostasis. Jejunal transcriptome profiles and the systemic endocrine regulation of mineral homeostasis were assessed (n = 80).Entities:
Keywords: laying hen line; mineral homeostasis; mineral requirements
Mesh:
Substances:
Year: 2021 PMID: 34187361 PMCID: PMC8243909 DOI: 10.1186/s12864-021-07814-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Plasma parameters referring to mineral homeostasis and growth of LSL and LB laying hens fed a standard control diet (Con), reduced Ca and P levels (LCaP), reduced Ca levels (LCa) or reduced P levels (LP). Values are displayed as mean ± SE. Data for inorganic P and Ca were taken from [17]. Superscripts indicate statistical significance (p < 0.05) between hen strains as capital letters or within strains between dietary groups as small letters
Fig. 2Venn diagram of differentially expressed genes identified in diet-specific comparisons between LSL and LB laying hens fed a standard control diet (Con), reduced Ca and P content (LCaP), reduced Ca content (LCa) or reduced P content (LP). The 1020 DEGs that are present in all dietary comparisons represent the laying hen strain-specific transcriptional patterns in the jejunum
Fig. 3KEGG pathway analysis of 1020 genes found to be consistently differentially expressed between LSL and LB strains covering all four dietary comparisons. The size of the pathway term represents the term p-value. Terms indicated by an asterisk were considered significant (Benjamini-Hochberg adjusted p-value < 0.05)
Fig. 4Principal component analysis of the LSL (A) and LB (B) laying hens fed a standard control diet (Con), reduced Ca and P levels (LCaP), reduced Ca levels (LCa) or reduced P levels (LP). The plots represent the first two components, which are derived from a variable selection approach (sPLS-DA) based on jejunal gene expression profiles
Fig. 5KEGG pathway analysis of genes found to be differentially expressed between Con and LP hens of the LSL strain. The size of the pathway designation represents the p-value. Terms indicated by an asterisk were considered significant (Benjamini-Hochberg adjusted p-value < 0.05)
Fig. 6KEGG pathway analysis of genes found to be differentially expressed between LCaP and LP hens of the LB strain. The size of the pathway designation represents the p-value. Terms indicated by an asterisk were considered significant (Benjamini-Hochberg adjusted p-value < 0.05)
Canonical pathways enriched by DEGs comparing Con and LP groups of LSL laying hens and LCaP and LP of LB laying hens
| Canonical pathways | z-score* | Molecules | |
|---|---|---|---|
| EIF2 Signaling | < 0.001 | 3.00 | AKT1,ATF3,EIF3K,FAU,KRAS,PAIP1,PIK3C2A,PIK3CG, RPL10A,RPL11,RPL12,RPL13,RPL21,RPL22,RPL23,RPL27A, RPL3,RPL30,RPL31,RPL32,RPL34,RPL35,RPL36,RPLP0, RPLP1,RPS10,RPS11,RPS15,RPS16,RPS17,RPS19,RPS20, RPS23,RPS3,RPS4X,RPS6,UBA52,XIAP |
| Regulation of eIF4 and p70S6K Signaling | < 0.001 | -1.89 | AKT1,EIF3K,EIF4EBP2,FAU,KRAS,MTOR,PAIP1,PIK3C2A, PIK3CG,RPS10,RPS11,RPS15,RPS16,RPS17,RPS19, RPS20,RPS23,RPS3,RPS4X,RPS6,RPS6KB1 |
| mTOR Signaling | 0.005 | -1.89 | AKT1,EIF3K,FAU,KRAS,MTOR,PIK3C2A,PIK3CG,PRR5L, RPS10,RPS11,RPS15,RPS16,RPS17,RPS19,RPS20,RPS23, RPS3,RPS4X,RPS6,RPS6KB1 |
| IL-4 Signaling | 0.013 | AKT1,JAK2,KRAS,MTOR,NFAT5,NFATC3,NR3C2, PIK3C2A,PIK3CG,RPS6KB1,SOCS1 | |
| Glucocorticoid Receptor Signaling | 0.034 | AKT1,BAG1,GTF2A1,GTF2H1,JAK2,KAT2B,KRAS,MAPK9, MED14,NCOA2,NFAT5,NFATC3,NR3C2,PIK3C2A,PIK3CG, POLR2E,POLR2L,PPP3CA,TAF4,TGFB1,YWHAH | |
| Agranulocyte Adhesion and Diapedesis | < 0.001 | ACTA2,CCL23,CD34,CDH5,CLDN10,CLDN2,CXCL12, CXCL14,FN1,JAM3,MMP10,MMP11,MMP17,MMP2, MMP9,MYH11,MYL4,MYL9,PODXL,PPBP,TNFRSF1A | |
| Granulocyte Adhesion and Diapedesis | < 0.001 | CCL23,CDH5,CLDN10,CLDN2,CXCL12,CXCL14,JAM3, MMP10,MMP11,MMP17,MMP2,MMP9,PPBP,SDC2, SDC3,THY1,TNFRSF1A | |
| GP6 Signaling Pathway | < 0.001 | 3.77 | COL13A1,COL16A1,COL18A1,COL1A1,COL1A2,COL3A1, COL4A1,COL4A2,COL4A6,COL5A1,COL5A2,COL6A1, COL6A2,COL6A3,LAMA1,LAMB1,LAMB3,NOX1 |
| Axonal Guidance Signaling | < 0.001 | ADAM19,ADAMTS1,ADAMTS13,ADAMTS9,BMP4,BMP6, CFL2,CXCL12,ECEL1,EFNB1,EPHB2,FZD6,GNB1L,HHIP, LINGO1,MMP10,MMP11,MMP17,MMP2,MMP9,MYL4, MYL9,NRP2,NTN3,NTN4,PDGFD,PLCD3,PLXND1,PTCH2, RASD2,SDC2,SEMA3F,TUBA4A,UNC5B,UNC5C,WNT2B, WNT4 | |
| Inhibition of Matrix Metalloproteases | < 0.001 | -1.13 | HSPG2,MMP10,MMP11,MMP17,MMP2,MMP9,SDC2, TFPI2,TIMP2 |
| Apelin Liver Signaling Pathway | 0.002 | 2.45 | COL18A1,COL1A1,COL1A2,COL3A1,IRS1,PDGFRB |
| Intrinsic Prothrombin Activation Pathway | 0.014 | 1.34 | COL18A1,COL1A1,COL1A2,COL3A1,PROS1 |
| Inhibition of Angiogenesis by TSP1 | 0.029 | 0.00 | CD36,HSPG2,MMP9,NOS3,SDC2,THBS1 |
| Leukocyte Extravasation Signaling | 0.044 | 1.90 | ACTA2,CDH5,CLDN10,CLDN2,CXCL12,CYBB,JAM3,MMP10, MMP11,MMP17,MMP2,MMP9,NOX1,THY1,TIMP2 |
* z-score: pathways with an absolute z-score ≥ 2 were considered significant. Positive and negative values indicate activation (in LSL: LP > Con; in LB: LCaP > LP) and inhibition (in LSL: LP < Con; in LB: LCaP < P)